STAGE III NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE III NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE III NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Hacked immune cells take on tough cancers
Disease control Recruiting nowThis study tests a new treatment called IOV-4001 for people with advanced melanoma or non-small-cell lung cancer. The treatment uses a patient's own tumor-fighting immune cells, which are collected, genetically modified to remove a 'brake' called PD-1, and then infused back after…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New lung cancer combo aims to boost treatment completion
Disease control Recruiting nowThis study tests a new way to give radiation therapy for stage III lung cancer that cannot be removed by surgery. It combines a smaller, faster radiation field with standard chemotherapy and an immunotherapy drug called durvalumab. The goal is to see if this approach helps more p…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Blood test may personalize lung cancer therapy
Disease control Recruiting nowThis study tests whether a simple blood test (ctDNA) can help doctors decide if adding chemotherapy to the immunotherapy drug cemiplimab works better for advanced lung cancer. About 63 people with stage IV or stage IIIB/C non-small cell lung cancer that hasn't been treated before…
Matched conditions: STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC